Anavex Life Sciences Corp. (AVXL)
5.30
+0.27
(+5.37%)
USD |
NASDAQ |
Jan 21, 16:00
5.295
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Market Cap: 473.54M for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CorMedix, Inc. | 577.52M |
| Verastem, Inc. | 479.03M |
| Ocugen, Inc. | 465.36M |
| AnaptysBio, Inc. | 1.292B |
| Replimune Group, Inc. | 569.50M |
Market Cap Related Metrics
| PEG Ratio | -1.699 |
| Price to Book Value | 4.992 |
| Price | 5.30 |
| Earnings Yield | -10.26% |
| PEGY Ratio | -1.699 |